Campbell, E. G., B. R. Clarridge, M. Gokhale, L. Birenbaum, S. Hilgartner, N. A. Holtzman, and D. Blumenthal. 2002. Data withholding in academic genetics: evidence from a national survey. JAMA. 287(15):473-480.

Carr, S., R. Aebersold, M. Baldwin, A. Burlingame, K. Clauser, and A. Nesvizhskii. 2004. The need for guidelines in publication of peptide and protein identification data: Working Group on Publication Guidelines for Peptide and Protein Identification Data. Mol. Cell. Proteomics. 3: 531-533.

Cho, M. K., S. Illangasekare, M. A. Weaver, D. G. Leonard, and J. F. Merz. 2003. Effects of patents and licenses on the provision of clinical genetic testing services. J. Mol. Diagn. 5(1):3-8.

Clark, J., J. Piccolo, B. Stanton, and K. Tyson. 2000. Patent Pools: A Solution to the Problem of Access in Biotechnology Patents. Available at Accessed June 21, 2005.

Collins, F. S. 1995. Positional cloning moves from perditional to traditional. Nat. Genet. 9(4): 347-350.

Collins, F. 2004. Intellectual property and genomics: a rocky relationship: remarks to Committee on Intellectual Property in Genomic and Protein Research and Innovation at February 11-12 meeting.

Crick, F. 1967. Of Molecules and Men. Seattle: University of Washington Press.

Dickson, D. 1993. UK clinical geneticists ask for ban on the patenting of human genes. Nature. 366(6454):391.

Dueker, K. S. 1997. Biobusiness on campus: commercialization of university-developed biomedical technologies. Food Drug Law J. 52(4):453-509.

Dulbecco, R. 1986. Mind from Matter? An Essay on Evolutionary Epistemology. Palo Alto: Blackwell Scientific Publications.

Easton, D. F., D. T. Bishop, D. Ford, and G. P. Crockford. 1993. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 52(4):678-701.

Eisenberg, R. S. 1990. Patenting the human genome. Emory Law J. 39(3):721-745.

Eisenberg, R. 1996. Intellectual property at the public-private divide: the case of large-scale cDNA sequencing. Univ. Chi. Law. School Roundtable. 3:557-573.

Eisenberg, R. S. 1997. Patenting research tools and the law. In: Intellectual Property Rights and Research Tools in Molecular Biology: Summary of a Workshop Held at the National Academy of Sciences. Washington, D.C.: National Academy Press.

Eisenberg, R. S. 2001. Bargaining over the transfer of proprietary research tools. In: Expanding the Boundaries of Intellectual Property, pp. 223-249, edited by Dreyfuss, R., D. L. Zimmerman, and H. First. Oxford: Oxford University Press.

Federal Trade Commission. 2003. To promote innovation: The proper balance of competition and patent law and policy. Washington, D.C.: Federal Trade Commission.

Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. Biotechnology Innovation Report 2004: Benchmarks. June 2004.

Firlik, A. D., and D. W. Lowry. 2000. Is academic medicine for sale? N. Engl. J. Med. 343(7):509-510.

Gluck, M., D. Blumenthal, and M. Stoto. 1987. University-industry research relationships in the life sciences: Implications for students and post-doctoral fellows. Research Policy. 16:327-336.

Graveley, B. R. 2005. Mutually exclusive splicing of the insect Dscam pre-mRNA directed by competing intronic RNA secondary structures. Cell. 123(1):65-73.

Gusella, J. F., N. S. Wexler, P. M. Conneally, S. L. Naylor, M. A. Anderson, R. E. Tanzi, P. C. Watkins, K. Ottina, M. R. Wallace, A.Y. Sakaguchi, A. B. Young, I. Shoulson, E. Bonilla, and J. B. Martin. 1983. A polymorphic DNA marker genetically linked to Huntington’s disease. Nature. 306(5940): 234-238.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement